{"data":[{"id":"7e2aa30e-3916-4280-80e8-6f1e0fd4d7e7","company_name":"小野薬品工業 株式会社","company_name_en":null,"corporate_number":null,"authority":"厚生労働省","authorities":["厚生労働省"],"authority_count":1,"action_types":["先駆け審査指定制度対象品目の募集"],"regional_record_count":1,"source_document_count":1,"law_name":"薬事法","action_type":"先駆け審査指定制度対象品目の募集","action_date":"2017-10-05","announcement_date":"2026-04-03","violation_summary":"ニボルマブ（遺伝子組換え）胆道癌","violation_summary_en":"Nivolumab (genetically modified) for biliary tract cancer","penalty_amount":null,"is_verified":false,"record_verified":false,"entity_match":{"status":"unresolved","confidence":85,"method":"nta_strict_name_nationally_unique","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"unreviewed","source_url":"https://www.mhlw.go.jp/stf/houdou/0000179802.html","url":"https://regbase.jp/enforcement/other-xiao-ye-yao-pin-gong-ye-20171005"},{"id":"df96ae0a-9bd7-4e2f-9c0d-235dc16b1c7b","company_name":"小野薬品工業株式会社","company_name_en":null,"corporate_number":null,"authority":"厚生労働省","authorities":["厚生労働省"],"authority_count":1,"action_types":["先駆け審査指定制度対象品目の募集"],"regional_record_count":1,"source_document_count":1,"law_name":"薬機法","action_type":"先駆け審査指定制度対象品目の募集","action_date":"2017-10-05","announcement_date":"2026-04-27","violation_summary":"厚生労働省は、革新的医薬品・医療機器・再生医療等製品を日本で早期に実用化することを目的として、その開発を促進するために、平成27年４月１日に「先駆け審査指定制度」を創設しました。","violation_summary_en":"The Ministry of Health, Labour and Welfare established the 'Designated Priority Review System' on April 1, 2015, to promote the development of innovative pharmaceuticals, medical devices, regenerative medicine products, and others, aiming for early practical application in Japan.","penalty_amount":null,"is_verified":false,"record_verified":false,"entity_match":{"status":"unresolved","confidence":85,"method":"nta_strict_name_nationally_unique","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"unreviewed","source_url":"https://www.mhlw.go.jp/stf/houdou/0000179802.html","url":"https://regbase.jp/enforcement/yakkiho-xiao-ye-yao-pin-gong-ye-20171005"},{"id":"39015569-446e-4daa-934b-b6d9b7c10309","company_name":"小野薬品工業株式会社","company_name_en":null,"corporate_number":null,"authority":"厚生労働省","authorities":["厚生労働省"],"authority_count":1,"action_types":["行政指導"],"regional_record_count":1,"source_document_count":1,"law_name":"薬機法","action_type":"行政指導","action_date":"2017-04-21","announcement_date":"2026-04-27","violation_summary":"「先駆け審査指定制度」の対象品目として指定された医薬品の名称、予定される効能または効果、申請者の氏名または名称を記載。","violation_summary_en":"Listed the names of pharmaceuticals designated as target items under the Accelerated Review Designation System, along with their intended effects or efficacy and the applicant's name or organization.","penalty_amount":null,"is_verified":false,"record_verified":false,"entity_match":{"status":"unresolved","confidence":85,"method":"nta_strict_name_nationally_unique","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"unreviewed","source_url":"https://www.mhlw.go.jp/stf/houdou/0000162665.html","url":"https://regbase.jp/enforcement/yakkiho-xiao-ye-yao-pin-gong-ye-20170421"}],"meta":{"query":"小野薬品工業株式会社","corporate_number":null,"law":null,"authority":null,"action_type":null,"count":3,"api_docs":"https://regbase.jp/api-docs","openapi_schema":"https://regbase.jp/api/openapi.json","llms":"https://regbase.jp/llms.txt","usage_note":"Use RegBase for targeted public-source screening of Japanese companies and enforcement records. Absence of returned records is not a clearance, legal opinion, sanctions result, or credit decision.","rate_limit":{"limit":10,"window_seconds":60,"remaining":3,"reset_at":"2026-08-04T16:27:52.014Z"},"daily_rate_limit":{"limit":300,"window_seconds":86400,"remaining":222,"reset_at":"2026-08-05T16:26:52.014Z"}}}